利用药物基因组数据在阿联人口中更安全地使用他类药物
Mais N Alqasrawi1, Zeina N Al-Mahayri1, Hiba Alblooshi1
1Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Current vascular pharmacology
|January 29, 2024
概括
在阿联的药物基因组测试显示了SLCO1B1和CYP2C9变体的高频率,预测了潜在的他类药物的副作用,并指导了更安全的药物选择. 这凸显了个性化医学的特定人口数据的重要性.
科学领域:
- 药物基因组学 药物基因组学
- 遗传学 是一个遗传学.
- 药物新陈代谢 药物新陈代谢
背景情况:
- 类药物是广泛使用的降脂药物,具有潜在的不良反应,特别是肌肉症状.
- 药物基因SLCO1B1,ABCG2和CYP2C9是他类药物安全性的关键生物标志物.
- 临床药物遗传学实施联盟 (CPIC) 提供了基于这些基因的他类药物使用指南.
研究的目的:
- 在阿联人口中调查药物基因变异.
- 根据遗传特征预测他类药物使用的安全性.
- 为个人化他类药物治疗建议提供信息.
主要方法:
- 分析了242个完整的外基因组测序数据集.
- 在SLCO1B1,ABCG2和CYP2C9.9中确定单核酸多态 (SNP) 频率.
- 哈普洛类型的注释和蛋白质功能的预测.
主要成果:
- 观察到SLCO1B1的高频率下降 (29.8%) 和功能差 (5.4%) 的等位基因.
- 低频率 (6%) 的ABCG2:rs2231142变种表明,罗斯瓦斯塔丁剂量限制的风险较低.
- 功能性受损的CYP2C9等位基因的高频率表明,弗卢瓦斯塔丁可能不太适合.
结论:
- 在阿联人口中确定了所有SLCO1B1和CYP2C9功能损害基因.
- 证明了特定人群的药物基因组数据对预测更安全的他类药物选择的有用性.
- 强调需要在未经研究的人群中进行药物基因组测试,以实现个性化医疗.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
01:12Analysis of Population Pharmacokinetic Data
257
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
257
01:19Factors Affecting Drug Biotransformation: Biological
153
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
153
01:19Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
39
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
39
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128